RecruitingNot Applicable

Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPOW.HER)

Thailand108 participantsStarted 2024-08-01

Plain-language summary

This study aims to develop and evaluate a multi-component mHealth intervention (mHC and FRESH) to reduce HIV-related and intersectional stigma and improve PrEP use among HIV-negative young transgender women (TGW) in Thailand.

Who can participate

Age range18 Years – 29 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-29 years * Male sex at birth * Self-identify as transgender woman/female spectrum * HIV-negative (laboratory confirmed) * Recent condomless sex * Able to understand Thai * Not on PrEP or poorly adherent (≤3 pills/week) Exclusion Criteria: * Serious cognitive or psychiatric condition affecting consent * Active suicidal ideation or major mental illness * Medical contraindications to PrEP * Enrolled in another HIV intervention study

What they're measuring

HIV-related stigma score

Timeframe: Baseline, Month 3, Month 6

PrEP uptake

Timeframe: Baseline through Month 6

PrEP adherence

Timeframe: Baseline, Month 3, Month 6

HIV testing uptake

Timeframe: Baseline, Month 3, Month 6

Trial details

NCT IDNCT07509827

SponsorInstitute of HIV Research and Innovation Foundation, Thailand

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-07-31

Contact for this trial

Nittaya Phanuphak, MD,PhD.

6681 825 3544 nittaya.p@ihri.org

View on ClinicalTrials.gov More HIV Prevention trials